Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „TIMI“
Suchtreffer
Begriffe & Kennungen
Nustendi · 4.5 · No clinically significant pharmacokinetic interactions were seen when ezetimibe was coadministered with atorva
Eintrag öffnenNustendi · 4.8 · Additional adverse reactions with ezetimibe Blood and lymphatic system Thrombocytopaenia Not known disorders I
Eintrag öffnenNustendi · 4.8 · Serious adverse reactions reported for ezetimibe were myopathy, rhabdomyolysis, hepatitis, hypersensitivity, a
Eintrag öffnenOptimismus
Eintrag öffnenParticle Swarm Optimization
Eintrag öffnenPositivität auf antimitochondriale Antikörper
Eintrag öffnenPrasugrel Viatris (previously Prasugrel Mylan) · 4.8 · 8/44 Patients <60 kg Non-CABG-related TIMI major or minor bleeding rates:
Eintrag öffnenPrasugrel Viatris (previously Prasugrel Mylan) · 4.8 · Bleeding risk associated with timing of loading dose in NSTEMI
Eintrag öffnenPrasugrel Viatris (previously Prasugrel Mylan) · 4.8 · In patients ≥60 kg and age <75 years, non-CABG-related TIMI major or minor bleeding rates were 3.6% for prasug
Eintrag öffnenPrasugrel Viatris (previously Prasugrel Mylan) · 4.8 · Non-CABG-related TIMI major or minor bleeding rates:
Eintrag öffnenPrasugrel Viatris (previously Prasugrel Mylan) · 4.8 · a Centrally adjudicated events defined by the Thrombolysis in Myocardial Infarction (TIMI) Study Group criteri
Eintrag öffnenProgrammieren, lineares
Eintrag öffnenPyrantelpamoat
Eintrag öffnenRanexa (previously Latixa) · 4.8 · The adverse event profile was generally similar in the MERLIN-TIMI 36 study. In this long term study, acute re
Eintrag öffnenRanexa (previously Latixa) · 4.8 · The adverse event profile was generally similar in the MERLIN-TIMI 36 study. In this long term study, acute re
Eintrag öffnenRanexa (previously Latixa) · 4.8 · The adverse event profile was generally similar in the MERLIN-TIMI 36 study. In this long term study, acute re
Eintrag öffnenRoteas · 4.5 · Platelet inhibitors In ENGAGE AF-TIMI 48 concomitant use of thienopyridines (e.g. clopidogrel) monotherapy was
Eintrag öffnenSchüchternheit
Eintrag öffnenSorafenib Accord · 4.5 · Neomycin Co-administration of neomycin, a non-systemic antimicrobial agent used to eradicate gastrointestinal
Eintrag öffnenSprycel · 4.8 · 17 Table 6b: Selected adverse reactions reported in phase III dose-optimisation study: Advanced phase CML and
Eintrag öffnen